We are live on !
Find out more
Axa Portfolio holdings
AUM
$98.9M
Turnover
20.75%
1-Year Est. Return
23.09%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+23.09%
3 Year Est. Return
+118.12%
5 Year Est. Return
+139.19%
10 Year Est. Return
+553.69%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow % of AUM
Cap. Flow %
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Avg Time Held
3.1
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.18T
| $671M | 2.73% |
9,143,116
-561,236
| -6% | -$36.1M |
2013 Q2
26 quarters
|
|
|
2
Microsoft
MSFT
$3.89T
| $597M | 2.43% |
3,784,111
+359,186
| +10% | +$52.8M |
2013 Q2
26 quarters
|
|
|
3
Linde
LIN
$242B
| $546M | 2.22% |
2,562,894
+142,492
| +6% | +$28.7M |
2018 Q4
4 quarters
|
|
4
Visa
V
$794B
| $423M | 1.72% |
2,250,279
-146,484
| -6% | -$26.4M |
2013 Q2
26 quarters
|
|
5
Alibaba
BABA
$235B
| $404M | 1.64% |
1,907,060
-398
| -0% | -$74.7K |
2014 Q3
21 quarters
|
|
6
Amazon
AMZN
$2.88T
| $395M | 1.61% |
4,274,860
-376,140
| -8% | -$33.3M |
2013 Q2
26 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$3.6T
| $339M | 1.38% |
5,072,940
-537,340
| -10% | -$34.7M |
2015 Q4
16 quarters
|
|
8
Thermo Fisher Scientific
TMO
$259B
| $249M | 1.01% |
765,343
-70,884
| -8% | -$21.5M |
2013 Q2
26 quarters
|
|
9
Meta Platforms (Facebook)
META
$1.64T
| $237M | 0.96% |
1,155,371
-156,311
| -12% | -$30.3M |
2013 Q2
26 quarters
|
|
10
Medtronic
MDT
$132B
| $225M | 0.91% |
1,979,682
-4,913
| -0.2% | -$539K |
2013 Q2
26 quarters
|
|
11
Alphabet (Google) Class A
GOOGL
$3.64T
| $218M | 0.89% |
3,254,960
+68,400
| +2% | +$4.41M |
2015 Q4
16 quarters
|
|
|
12
Mastercard
MA
$576B
| $203M | 0.82% |
679,259
+139,987
| +26% | +$39.5M |
2013 Q2
26 quarters
|
|
13
UnitedHealth
UNH
$365B
| $203M | 0.82% |
689,459
-26,857
| -4% | -$7.03M |
2013 Q2
26 quarters
|
|
14
Intuitive Surgical
ISRG
$154B
| $198M | 0.8% |
1,003,524
+57,150
| +6% | +$10.7M |
2015 Q4
16 quarters
|
|
15
Qualcomm
QCOM
$185B
| $195M | 0.79% |
2,204,858
-303,739
| -12% | -$25.4M |
2013 Q2
26 quarters
|
|
16
Fidelity National Information Services
FIS
$15.2B
| $191M | 0.78% |
1,376,065
-211,718
| -13% | -$28.4M |
2013 Q2
26 quarters
|
|
17
Intel
INTC
$317B
| $179M | 0.73% |
2,983,375
+404,981
| +16% | +$22.7M |
2013 Q2
26 quarters
|
|
18
Cisco
CSCO
$377B
| $178M | 0.72% |
3,710,934
-250,180
| -6% | -$11.6M |
2013 Q2
26 quarters
|
|
19
PepsiCo
PEP
$198B
| $176M | 0.72% |
1,288,316
+68,968
| +6% | +$9.39M |
2013 Q2
26 quarters
|
|
|
20
Pfizer
PFE
$165B
| $174M | 0.71% |
4,668,668
+1,864,795
| +67% | +$66.4M |
2013 Q2
26 quarters
|
|
21
Verizon
VZ
$192B
| $166M | 0.68% |
2,711,288
+10,006
| +0.4% | +$604K |
2013 Q2
26 quarters
|
|
22
Merck
MRK
$364B
| $161M | 0.66% |
1,857,282
+110,334
| +6% | +$9.06M |
2013 Q2
26 quarters
|
|
|
23
Ferrari
RACE
$72B
| $152M | 0.62% |
916,972
+170,842
| +23% | +$27.6M |
2016 Q1
15 quarters
|
|
24
Adobe
ADBE
$94.6B
| $150M | 0.61% |
453,893
-158,694
| -26% | -$46.7M |
2013 Q2
26 quarters
|
|
25
Honeywell
HON
$70.6B
| $149M | 0.61% |
894,272
+21,572
| +2% | +$3.53M |
2013 Q2
26 quarters
|
|
Similar funds
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.